Is rosuvastatin cost-effective compared with atorvastatin in reaching cholesterol goals?
Rosuvastatin has the same acquisition costs as and is more efficacious than atorvastatin in lowering LDL-C and treating patients to target LDL-C levels.
These results suggest that olanzapine is correlated with weight gain and the risks associated with obesity.